{"id":203541,"name":"LIVANOVA USA, INC.","slug":"livanova-usa-inc","state":"TX","country":"United States of America","description":"","totalSpending":2730000,"filings":29,"yearlySpending":[{"year":2019,"income":230000},{"year":2020,"income":320000},{"year":2021,"income":300000},{"year":2022,"income":370000},{"year":2023,"income":400000},{"year":2024,"income":480000},{"year":2025,"income":630000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"VET","display":"Veterans"},{"code":"IMM","display":"Immigration"},{"code":"ENV","display":"Environment/Superfund"}],"firms":["LIVANOVA USA, INC."],"lobbyists":["JOHN VERSAGGI"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Office of Management & Budget (OMB)"],"sampleDescriptions":["Issues impacting the medical device industry.","S. 692, H.R. 2207, Protect Medical Innovation Act, regarding all provisions.","Issues relating to Medicare beneficary access to innovative therapies for serious mental illness.","S. 692, H.R. 2207, Protect Medical Innovation Act, regarding all provisions.","Issues relating to Medicare beneficary access to innovative therapies for serious mental illness."]}